Clinical Trial Update: A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections [Phase 2]

View source ↗

Summary

A Phase II randomized, double-blind, placebo-controlled trial evaluated inhaled interferon gamma-1b in combination with antimycobacterial therapy for pulmonary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Infection

Drugs mentioned

• Antimycobacterial therapy (multi-drug regimen) (antimycobacterial therapy)
• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mycobacterium Avium-Intracellulare Infection | Phase 2 | Status: COMPLETED